Relief Therapeutics Holding AG (RLFTF)

[tcm55]

The current 2b Trial which is probably progressing to Phase 3 trial after reviewed data, the Expanded use authorization the IV version of RLF100. 3 doses of 12 hr Infusions. Some logistic issues and a called for price of 3X Remdesivir.$10K?.
We expect the new Emergency use protocol to be the IV version too, right?
The Inhaler trials are still planned and now could be paid for after last GEM financing. Inhaler may be the Golden ticket due to much easier logistics which could have easier worldwide distributions and pricing. Both Inhaler Trials are awaiting Recruitment status.

https://clinicaltrials.gov/ct2/results?cond=&term=aviptadil&cntry=&state=&city=&dist=